{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:15:27Z","timestamp":1778660127386,"version":"3.51.4"},"reference-count":59,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Pfizer Pharma GmbH"},{"name":"Roche"},{"name":"Bristol-Myers Squibb"},{"DOI":"10.13039\/100010544","name":"Exelixis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010544","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Novartis and Astellas"},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lilly and Celgene"},{"name":"(GSK)"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2018,4,30]]},"DOI":"10.2217\/fon-2017-0455","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T11:42:12Z","timestamp":1513856532000},"page":"861-875","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["Individualized Dosing with Axitinib: Rationale and Practical Guidance"],"prefix":"10.1080","volume":"14","author":[{"given":"Manuela","family":"Schmidinger","sequence":"first","affiliation":[{"name":"Clinical Division of Oncology, Department of Medicine I &amp; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romano","family":"Danesi","sequence":"additional","affiliation":[{"name":"Department of Clinical &amp; Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Jones","sequence":"additional","affiliation":[{"name":"Institute of Cancer Sciences, University of Glasgow, The Beatson West of Scotland Cancer Centre, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"McDermott","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, St Vincent\u2019s University Hospital &amp; The Adelaide &amp; Meath Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda","family":"Pyle","sequence":"additional","affiliation":[{"name":"Renal Cancer Unit, Department of Medicine, Royal Marsden Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Rini","sequence":"additional","affiliation":[{"name":"Department of Hematology &amp; Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"N\u00e9grier","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, University of Lyon, Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161210789941847"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.9746"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-8-913"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e3280109411"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.24.1883"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2015.05.009"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318292b931"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv103"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70464-9"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61613-9"},{"key":"e_1_3_3_13_1","first-page":"10","volume-title":"Principles of Pharmacology","author":"Brenner GM","year":"2000","unstructured":"Brenner GM . Chapter 2: Pharmacokinetics. In: Principles of Pharmacology. WB Saunders Co, PA, USA, 10\u201327 (2000)."},{"key":"e_1_3_3_14_1","volume-title":"Introduction To Pharmacokinetics And Pharmacodynamics: The Quantitative Basis Of Drug Therapy","author":"Tozer TN","year":"2006","unstructured":"Tozer TN , RowlandM. Introduction To Pharmacokinetics And Pharmacodynamics: The Quantitative Basis Of Drug Therapy. Lippincott Williams & Wilkins, Philadelphia, PA, USA (2006)."},{"key":"e_1_3_3_15_1","unstructured":"Pfizer Pharma GmbH\n. Inlyta (axitinib) summary of product characteristics. 2015. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002406\/WC500132188.pdf."},{"key":"e_1_3_3_16_1","unstructured":"Bayer Pharma AG\n. Nexavar (sorafenib) summary of product characteristics. 2015. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000690\/WC500027704.pdf."},{"key":"e_1_3_3_17_1","unstructured":"Novartis\n. Votrient (pazopanib) summary of product characteristics. 2015. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001141\/WC500094272.pdf."},{"key":"e_1_3_3_18_1","unstructured":"Novartis\n. Afinitor (everolimus) summary of product characteristics. 2015. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001038\/WC500022814.pdf."},{"key":"e_1_3_3_19_1","unstructured":"Pfizer Pharma GmbH\n. Sutent (sunitinib) summary of product characteristics. 2015. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000687\/WC500057737.pdf."},{"key":"e_1_3_3_20_1","unstructured":"Ipsen Pharma\n. Cabometyx (cabozantinib) summary of product characteristics. 2016. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/004163\/WC500214071.pdf."},{"key":"e_1_3_3_21_1","unstructured":"Eisai Europe Ltd\n. Kisplyx (lenvatinib) summary of product characteristics. 2016. www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/004224\/WC500216237.pdf."},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.192"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2010.08.006"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.09.007"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-015-0214-x"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0055"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12496"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0068-3"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.9.652"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.07.014"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70285-1"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.7034"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.73"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.143"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2016.04.005"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis210"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.051193"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj466"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1171-8"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0652"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.2165\/11591240-000000000-00000"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0264"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-5270"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-011-0154-3"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2015.07.001"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.244"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70093-7"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e31827b45f9"},{"key":"e_1_3_3_49_1","first-page":"1","article-title":"An individualized dose titration schedule of axitinib in patients with metastatic renal cell carcinoma","volume":"116","author":"Allman K","year":"2015","unstructured":"Allman K , GarciaJA, GrivasPet al. An individualized dose titration schedule of axitinib in patients with metastatic renal cell carcinoma. BJU Int.116, 1\u201327 (2015).","journal-title":"BJU Int."},{"key":"e_1_3_3_50_1","first-page":"1","article-title":"Clinical effect of TKI dose-escalation after disease progression in patients with metastatic renal cell carcinoma","volume":"116","author":"Ornstein MC","year":"2016","unstructured":"Ornstein MC , WoodL, ElsonPet al. Clinical effect of TKI dose-escalation after disease progression in patients with metastatic renal cell carcinoma. BJU Int.116, 1\u201327 (2016).","journal-title":"BJU Int."},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmonc.2011.11.002"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-012-9796-8"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.5_suppl.354"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv147"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2332"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510665"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510016"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw373.01"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw373.03"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215397109"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2017-0455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:44:26Z","timestamp":1719125066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2017-0455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,4,30]]}},"alternative-id":["10.2217\/fon-2017-0455"],"URL":"https:\/\/doi.org\/10.2217\/fon-2017-0455","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}